Lee CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al. Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis. Cancer 2021 Mar 19. doi: 10.1002/cncr.33517.
PMID: 33740262